Schematic representation of RBM-HFtn structure with ferritin as scaffold (blue) fused with RBM of SARS-CoV-2 spike glycoprotein (red); The RBM-HFtn is capable of complexing with ACE2 (green) (A).

BEIJING--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315) today officially launched its fully human heavy chain antibody platform, RenNano™. RenNano ...

In the IGHV3-53/IGHV3-66 anti- SARS-CoV-2 antibodies, two primary heavy chain genes (IGHV3-53 and IGHV3-66) pair with at least 14 light-chain genes to create a diverse repertoire of antibodies. 12 ...

Moderna's appetite for antibody tech spurs $6M bet on Nona's heavy chain only platform By Nick Paul Taylor Nov 11, 2022 7:30am Moderna Harbour BioMed antibody messenger RNA ...

Osaka University and Otsuka Pharmaceutical Co., Ltd. entered into an exclusive, worldwide license agreement for Otsuka to use R8H283, a novel antibody that recognizes the CD98 heavy chain ...